Loading organizations...
Case Technology Ventures (CTV) functions as Case Western Reserve University’s multi-million dollar technology validation fund. It provides crucial early-stage capital and strategic support, bridging the funding gap for intellectual property emerging from the university. CTV focuses on creating new companies around promising research, accelerating commercialization by de-risking technologies for further investment.
Established by Case Western Reserve University, CTV was conceived to address the challenge of translating academic research into market-ready ventures. Its inception reflects the university's commitment to fostering innovation and commercializing its scientific breakthroughs. This initiative leverages the institution's research capabilities, ensuring intellectual assets contribute to economic and societal progress.
CTV primarily supports university researchers and nascent startup teams spun out of Case Western Reserve, offering resources to advance technologies beyond initial proof-of-concept. The fund’s long-term vision involves cultivating a robust innovation ecosystem, creating successful enterprises that deliver groundbreaking academic discoveries, generating both economic returns and significant societal benefit.
Case Tech Ventures has 2 tracked investments across 1 company. The latest tracked deal is $3.5M Other Equity in Neuros Medical in July 2012.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 18, 2012 | Neuros Medical | $3.5M Other Equity | Boston Scientific, Stephen R. Haynes | BlueTree Allied Angels, JumpStart Ventures, Modelvest, North Coast Ventures, Ohio Tech Angel Fund, Physician Investment Group, Queen City Angels, RiverVest Venture Partners |
| Mar 17, 2009 | Neuros Medical | $380K Other Equity | Case Tech Ventures, Lynn ANN Gries | — |